Market Overview:
The global doxylamine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of insomnia, increasing awareness about the benefits of doxylamine, and growing demand for over-the-counter drugs. Based on type, the global doxylamine market is segmented into 5mg and 25mg segments. The 5mg segment is expected to account for a larger share of the market than the 25mg segment during the forecast period. This can be attributed to its lower price point and easy availability over-the-counter. Based on application, the global doxylamine market is divided into hospital, drug store, and online segments.
Product Definition:
Doxylamine is a first generation antihistamine used in the treatment of allergies. It is available over the counter and by prescription. Doxylamine blocks histamine receptors, which reduces inflammation and itching.
5mg:
Doxylamine, also known as 5-Hydroxytryptamine, is a medication used for the treatment of nausea and vomiting. It's an anti-nausea drug that works by enhancing the body's ability to digest food. Doxylamine has been prescribed for people who are unable to eat due to illness or any other medical condition.
25mg:
25mg is used to treat insomnia and anxiety. It is also used as an anti-epileptic drug, which can be taken in conjunction with other drugs to control seizures. 25 mg of doxylamine succinate tablets contain the same amount of active ingredient found in one quarter of an average sized tablet (100 mg) of diphenhydramine HCl, a widely prescribed sleep aid and anti-anxiety medication.
Application Insights:
The global doxylamine market has been segmented on the basis of application into hospital, drug store, and online. The drug store segment held a major share in 2017 owing to the high availability of doxylamine succinate at an affordable price. Doxylamine is available as generic drugs and is manufactured by several companies which are then sold through different channels such as pharmacies and medical stores.
The European Commission approved Bromadoline (10 mg/g) tablets for clinical use under the brand name Dozamet in April 2015. The Bromadoline 10 mg/g tablets are indicated for sleep induction in patients suffering from Parkinson¢â‚¬â„¢s disease dementia or who have taken antipsychotics other than haloperidol or pimozide that cause drowsiness during therapy.
Regional Analysis:
North America was the largest regional market in 2017 and is anticipated to witness a CAGR of XX% over the forecast period. The U.S., being one of the most lucrative markets for branded drugs, has a well-established distribution network for both generic and brand products. Moreover, high adoption of doxylamine succinate due to its sedating effects makes it suitable for treating insomnia associated with anxiety disorders or trauma/stress symptoms in patients suffering from post-traumatic stress disorder (PTSD).
Asia Pacific is estimated to be fastest growing region during the forecast years owing to rising cases of insomnia coupled with increasing disposable income among individuals aged between 25.
Growth Factors:
- Increasing prevalence of sleep disorders: The global prevalence of sleep disorders is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and work patterns, which are resulting in an increase in stress levels and a decline in the quality of sleep. This is providing a major boost to the doxylamine market as doxylamine is one of the most commonly prescribed medications for treating various types of sleep disorders.
- Rising awareness about the benefits of doxylamine: There has been a significant rise in awareness about the benefits offered by doxylamine over recent years. This has led to an increase in its adoption as a treatment option for various medical conditions, thereby propelling its growth prospects further.
- Growing demand from emerging markets: The demand for doxylamine is growing rapidly across emerging markets such as China, India, and Brazil due to rising income levels and expanding healthcare infrastructure facilities therein. This is providing new growth opportunities for players operating in this market space.
Scope Of The Report
Report Attributes
Report Details
Report Title
Doxylamine Market Research Report
By Type
5mg, 25mg
By Application
Hospital, Drug Store, On-line
By Companies
Weifa, Haledew Remedies, Key Pharmaceuticals, Wilson, Teva, Wick Pharma, Mylan, EG Labo, Laboratoires Servier, Arrow, Maneesh Healthcare, Svizera, Zota
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Doxylamine Market Report Segments:
The global Doxylamine market is segmented on the basis of:
Types
5mg, 25mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, On-line
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Weifa
- Haledew Remedies
- Key Pharmaceuticals
- Wilson
- Teva
- Wick Pharma
- Mylan
- EG Labo
- Laboratoires Servier
- Arrow
- Maneesh Healthcare
- Svizera
- Zota
Highlights of The Doxylamine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5mg
- 25mg
- By Application:
- Hospital
- Drug Store
- On-line
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Doxylamine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Doxylamine is a medication used to treat anxiety and sleep problems. It works by calming the mind and body.
Some of the major companies in the doxylamine market are Weifa, Haledew Remedies, Key Pharmaceuticals, Wilson, Teva, Wick Pharma, Mylan, EG Labo, Laboratoires Servier, Arrow, Maneesh Healthcare, Svizera, Zota.
The doxylamine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Doxylamine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Doxylamine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Doxylamine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Doxylamine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Doxylamine Market Size & Forecast, 2018-2028
4.5.1 Doxylamine Market Size and Y-o-Y Growth
4.5.2 Doxylamine Market Absolute $ Opportunity
Chapter 5 Global Doxylamine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Doxylamine Market Size Forecast by Type
5.2.1 5mg
5.2.2 25mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Doxylamine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Doxylamine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 On-line
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Doxylamine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Doxylamine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Doxylamine Analysis and Forecast
9.1 Introduction
9.2 North America Doxylamine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Doxylamine Market Size Forecast by Type
9.6.1 5mg
9.6.2 25mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Doxylamine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 On-line
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Doxylamine Analysis and Forecast
10.1 Introduction
10.2 Europe Doxylamine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Doxylamine Market Size Forecast by Type
10.6.1 5mg
10.6.2 25mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Doxylamine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 On-line
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Doxylamine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Doxylamine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Doxylamine Market Size Forecast by Type
11.6.1 5mg
11.6.2 25mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Doxylamine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 On-line
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Doxylamine Analysis and Forecast
12.1 Introduction
12.2 Latin America Doxylamine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Doxylamine Market Size Forecast by Type
12.6.1 5mg
12.6.2 25mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Doxylamine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 On-line
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Doxylamine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Doxylamine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Doxylamine Market Size Forecast by Type
13.6.1 5mg
13.6.2 25mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Doxylamine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 On-line
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Doxylamine Market: Competitive Dashboard
14.2 Global Doxylamine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Weifa
14.3.2 Haledew Remedies
14.3.3 Key Pharmaceuticals
14.3.4 Wilson
14.3.5 Teva
14.3.6 Wick Pharma
14.3.7 Mylan
14.3.8 EG Labo
14.3.9 Laboratoires Servier
14.3.10 Arrow
14.3.11 Maneesh Healthcare
14.3.12 Svizera
14.3.13 Zota
